Variable | Category | PM % (n) | Unadjusted OR (95% CI)a | Adjusted OR (95% CI)b | p-value |
---|---|---|---|---|---|
Setting | Semi rural (238) | 21.8 (52) | 1.56 (0.99–2.56) | 1.85 (1.12–3.04) | 0.016 |
Semi urban (227) | 15.0 (34) | REF | REF | ||
Age group (years)c | < 21 (90) | 27.8 (25) | 2.48 (1.37–4.51) | NA | |
21–25 (144) | 20.8 (30) | 1.70 (0.98–2.95) | |||
> 25 (231) | 13.4 (31) | REF | |||
Parity | Primiparae (139) | 24.5 (34) | 2.09 (1.19–3.68) | 2.13 (1.19–3.81) | 0.011 |
Secundiparae (132) | 19.7 (26) | 1.59 (0.87–2.88) | 1.74 (0.94–3.23) | 0.078 | |
Multiparae (194) | 13.4 (26) | REF | REF | ||
IPTp-SP Dosage frequency | ≥ 3 SP dose (203 | 21.7 (44) | 1.66 (0.89–3.10) | 2.36 (1.41–4.87) | 0.021 |
2 SP dose (150) | 17.3 (26) | 1.26 (0.64–2.48) | 1.43 (0.70–2.90) | 0.324 | |
≤ 1 dose (112) | 14.3 (16) | REF | REF | ||
Trimester of first ANC | First (33) | 10.5 (9) | 0.22 (0.10–0.52) | 0.69 (0.25–1.80) | 0.448 |
Second (339) | 16.2 (55) | 0.60 (0.34–1.05) | 0.39 (0.20–0.74) | 0.004 | |
Third (90) | 24.4 (22) | REF | REF | ||
ITN usage | Yes (315) | 19.0 (60) | 1.12 (0.68–1.87) | 1.02 (0.6–1.73) | 0.941 |
No (150) | 17.3 (17) | REF |